The inhibition of mitochondrial (pl 5) horse liver aldehyde dehydrogenase by disulfiram (tetraethylthiuram disulphide) was investigated to determine if the drug was an active-site-directed inhibitor. Stoichiometry of inhibition was determined by using an analogue, [35S]tetramethylthiuram disulphide. A 50%O loss of the dehydrogenase activity was observed when only one site per tetrameric enzyme was modified, and complete inactivation was not obtained even after seven sites per tetramer were modified. Modification of only two sites accounted for a loss of 75% of the initial catalytic activity. The number of functioning active sites per tetrameric enzyme, as determined by the magnitude of the pre-steady-state burst of NADH formation, did not decrease until approx. 75% of the catalytic activity was lost. These data indicate that disulfiram does not modify the essential nucleophilic amino acid at the active site of the enzyme. The data support an inactivation mechanism involving the formation of a mixed disulphide with a non-essential cysteine residue, resulting in a lowered specific activity of the enzyme.
INTRODUCTION

Disulfiram (tetraethylthiuram disulphide) is a drug
commonly given to alcoholics to deter them from drinking ethanol. The drug is an inhibitor in vivo of aldehyde dehydrogenase (aldehyde: NAD+ oxidoreductase, EC 1.2.1.3; ALDH). The inactivation of ALDH in vivo results in an increase in blood acetaldehyde after the ingestion of ethanol, and is followed by the manifestation of the physiological disulfiram-ethanol reaction (Kitson, 1977; Faiman, 1979) .
Numerous studies in vivo and in vitro revealed that the drug is an irreversible covalent inhibitor of ALDH. It was demonstrated that the number of thiol groups decreased in human (Vallari & Pietruszko, 1982) and sheep (Kitson, 1983) liver ALDH after the enzyme had been treated with disulfiram. It was originally proposed that the modified cysteine residue was at the active site of the enzyme (Deitrich & Erwin, 1971) . More recent studies with human (Vallari & Pietruszko, 1982) and sheep (Kitson, 1983) cytosol ALDH revealed that a thiol group from a second cysteine residue can displace the bound inhibitor, resulting in an internal disulphide bond being formed.
Extensive studies in vitro on the inhibition of the enzyme isolated from sheep liver cytosol and mitochondria have been performed. The cytosol enzyme retained 10% of its initial activity (Kitson, 1978) , whereas the mitochondrial enzyme retained 50 O (Hart & Dickinson, 1977) . Thus it appears that disulfiram may not be an active-site-directed reagent. Further, with sheep (Dickinson et al., 1981; Kitson, 1982) and human (Vallari & Pietruszko, 1982) liver enzyme, maximal, but not total, inhibition is achieved when only two mol of disulfiram have been bound per mol of tetrameric enzyme.
To determine whether or not the compound was attacking the active site, we chose a different approach. It has been shown with horse liver ALDH (Weiner et al., 1976) that there is a pre-steady-state burst of NADH formation. The magnitude of the burst represents the number of functioning active sites (Takahashi & Weiner, 1980 Radioactivity was counted in 3 ml of fluor (Tank & Weiner, 1979) Neims et al. (1966) , and shown to occur by Kitson (1982) . The number of sites modified was calculated from the specific radioactivity associated with the modified enzyme, assuming the following inactivation scheme:
( 1) where ESH represents reactive cysteine residues of the enzyme, R is the dimethylamine group, and n is the stoichiometry. Pre-steady-state burst studies of inactivated enzyme
The pre-steady-state burst magnitude of NADH formation in the dehydrogenase reaction was determined as described by Weiner et al. (1976) was not obtained even after 7 mol of inhibitor was covalently bound per mol of enzyme. It appears that approx. 10-25% of the activity remained after the initial two sites were modified. The insert in Fig. 1 shows a replot of the data on the assumption that 22% activity remained in the modified enzyme (Af). Hence, there was essentially a linear loss of catalytic activity as the first two sites were modified. Non-active-site modification of ALDH by disulfiram It was not possible to determine by sequence analysis if the disulfiram analogue was labelling the catalytically essential residues, since the amino acids at the active site of mitochondrial ALDH are not known. If disulfiram was labelling the catalytic residues, then that molecule of enzyme would be totally inactive. If the inhibitor was modifying a non-essential amino acid, then the catalyticcentre activity of the modified enzyme could decrease, but the number of active sites would remain unaltered. To determine if the disulfiram modification affected the number of active sites, the magnitude of the pre-steadystate burst ofNADH formation, which is proportional to active-site concentration, was correlated with the specific activity of the enzyme remaining after modification. The data presented in Fig. 2 clearly reveal that the magnitude of the pre-steady-state burst does not decrease until approx. 750 of the catalytic activity is lost. This shows that disulfiram does not react initially with an essential amino acid at the active site of the enzyme. Rate of inactivation of ALDH by disulfiram Inactivation of ALDH by disulfiram produced a biphasic inactivation curve when the log of per cent activity remaining versus time was plotted. The slower second phase is presented in Fig. 3 . The inactivation rate was dependent on disulfiram concentration. A similar biphasic inactivation curve was obtained when the tetramethyl derivative was employed. The presence of NAD+ decreased both the rapid and the slow disulfiram inactivation. Enzyme incubated with 100 ,tM-disulfiram in the presence of 370 ,M-NAD+ retained 7000 of its catalytic activity after 20 min, compared with 100% in the absence of NAD+. The presence of both NAD+ and aldehyde afforded just slightly better protection. Aldehyde alone was not effective at protecting the enzyme against inactivation.
Esterase activity was more resistant than was the dehydrogenase activity to inactivation by disulfiram, as shown in Fig. 3 . The presence of NAD+ (370 /uM) afforded only slight protection against inactivation (results not shown). There is some controversy as to whether or not the dehydrogenase reaction utilizes the same active site as does the esterase reaction (e.g. Duncan, 1985) . In either case the catalytic residue
The magnitude of the pre-steady-state burst of NADH is equal to the number of mol of active sites remaining per mol of enzyme. The steady-state velocity was the percentage of activity remaining. The enzyme was incubated at pH 7.5 in 50 mM-phosphate buffer containing 10% ethanol. After a period of time, concentrated NAD+ and aldehyde were added to the cuvette to initiate the reaction, which was monitored with a Gilford spectrophotometer as previously described (Weiner et al., 1976 (Fig. 1) . (Takahashi & Weiner, 1980 ) that millimolar Mg2+ ions caused an increase in enzymic activity. Rates of disulfiram inhibition were performed in the presence or absence of the ions. The rates of inactivation were the same (results not shown). No stoichiometry experiments were performed, owing to lack of label.
DISCUSSION
Though it has been known for many years that disulfiram inactivates ALDH in vitro, the detailed aspects of the inactivation have not been well characterized. It was proposed that the compound covalently binds to the active site of the enzyme (Deitrich & Erwin, 1971) . The data from the present study clearly show that disulfiram is not an active-site-directed reagent with the horse mitochondrial enzyme.
It was possible to achieve a high degree of inactivation of the mitochondrial enzyme only when many disulfiram molecules were attached to the enzyme. However, most (approx. 80%o) of the enzyme activity, but not the total, was lost when only 2 mol of disulfiram was bound per mol of tetrameric enzyme. Most significant was the observation that this modified enzyme still had its full complement of active sites, as determined by the magnitude of the pre-steady-state burst. The magnitude of the burst is independent of the specific activity of the enzyme; hence, if active sites were destroyed by the inhibitor, a proportional decrease in burst magnitude would have been observed. This titration of the number of functioning active sites remaining in the chemically modified enzyme is analogous to what has been performed with proteolytic enzymes (Ray & Koshland, 1963) and with this ALDH (Takahashi & Weiner, 1980; Takahashi et al., 1981) . The value of such a titration is that the results are independent of the catalytic activity of the enzyme. Hence, it differentiates between chemical modification at the active site, which totally inactivates the enzyme, and modification at a non-active-site residue, which only decreases specific activity.
It was demonstrated with human (Vallari & Pietruszko, 1982) and then with sheep (Kitson, 1982) cytosolic ALDH that the bound diethyldithiocarbamate could be displaced by a second cysteine residue, forming an internal disulphide bond in the enzyme. This reaction did not occur with the horse mitochondrial enzyme under the conditions of the experiment. We found 2 mol of dimethyldithiocarbamate bound per mol of tetrameric ALDH and an equal amount of free dimethyldithiocarbamate, proving that the bound reagent was not displaced from the enzyme. These results are similar to those found with the sheep enzyme (Kitson, 1982) if proper reaction conditions are employed.
Since the 35S label remained in the modified enzyme, it was possible to calculate the number of sites modified. The correlation between catalytic activity remaining and the number of sites modified showed that, as the first 1-1.5 sites were modified, a linear decrease in catalytic activity occurred. It was found that approx. 2 critical sites were modified per tetrameric enzyme. The sheep enzymes were shown also to be inactivated by just 2 mol of disulfiram binding per mol of tetrameric enzyme (Hart & Dickinson, 1977; Kitson, 1978; Dickinson et al., 1981) . Why just 2 mol of disulfiram initially bind per mol of tetrameric enzyme is not known. It may somehow be related to the fact that the enzyme functions with half-of-the-site reactivity when in the tetrameric state (Weiner et al., 1976; Takahashi & Weiner, 1980; Takahashi et al., 1981) . Steric hindrance may also play a role in the stoichiometry of disulfiram inactivation (Mackerell et al., 1985) .
Finding that disulfiram is not attacking an essential thiol residue does not rule out a thiol group being at the active site. Hart & Dickinson (1977) observed complete inactivation of sheep mitochondrial ALDH by 5,5'-dithiobis-(2-nitrobenzoate) with modification of four thiol residues per tetramer. Thus far, however, no one has truly identified the active site of ALDH, though the sequences for the human cytosolic and human mitochondrial enzymes are known Hemple et al., 1984 Hemple et al., , 1985 . All evidence, kinetic (Weiner et al., 1976; Feldman & Weiner, 1972b) and spectroscopic (Buckley & Dunn, 1982) , leads one to conclude that aldehyde oxidation proceeds through an acyl intermediate. The acylated residue could be serine rather than cysteine. More recent spectroscopic data, however, make it appear that the residue is indeed cysteine (Dickinson, 1985; Dunn & Buckley, 1985) .
Finding that disulfiram is not an active-site inhibitor of ALDH explains why experiments in vivo do not produce fully inhibited enzymes. Studies in vitro with human (Greenfield & Pietruszko, 1977) , bovine (Sugimoto et al., 1976) , sheep (Allanson & Dickinson, 1984; Dickinson et al., 1981; Kitson, 1975) and horse liver enzyme (Eckfeldt et al., 1976) showed that the cytosol enzymes were more susceptible to inhibition by the drug than were the mitochondrial enzymes. The mitochondria, however, are the major site ofacetaldehyde oxidation, at least in the rat (Svanas & Weiner, 1985; Weiner, 1979) and monkey (Havre et al., 1976) . Thus the person taking the drug may still have some limited capacity to oxidize aldehydes and may be afforded minimal protection against their toxic effects.
